Post by Admin on Jul 19, 2004 18:36:29 GMT -5
Desert Health Products, Inc. is Approved for Trading on The Frankfurt Stock Exchange
Wednesday February 11, 8:00 am ET
SCOTTSDALE, Ariz., Feb. 11, 2004 (PRIMEZONE) -- Desert Health Products, Inc. (OTC BB: DHPI.OB - News) headquartered in Scottsdale, Arizona, today announced that it has met admission requirements and has been accepted for listing onto the Frankfurt Stock Exchange. Trading will commence on February 11th, 2004, under the symbol DHE and the German cusip (WKN) number A0BMFX.
``Listing on the Frankfurt exchange will increase the profile of Desert Health with investors, both institutional and retail, in Germany and across Europe,'' stated Johnny Shannon, Chairman and CEO of Desert Health Products, Inc. ``We have had high levels of interest expressed from European investors, and this opportunity to broaden our shareholder base comes at an excellent time for the company as we move into the next phase of our corporate growth initiative.''
``Desert Health has an exciting business concept, and we firmly believe that the company will quickly establish awareness throughout Europe through its market presence in Germany,'' said Jan-Eric Soetbeer, Managing Director of OTC Consulting & Financial Services in Germany, who assisted the company in the listing application process. ``There has already been a significant level of interest from investors who have identified Desert Health Products' unique business model, which carries both long-term potential for accelerated revenue growth and substantial profitability.''
The Frankfurt Stock Exchange is the world's third largest organized exchange-trading market in terms of turnover and dealings in securities. It accounts for more than 85 percent of the total securities turnover in Germany and is the largest of the eight German stock exchanges. It ranks third in the world behind the NYSE and NASDAQ markets. It offers its clients only floor trading through brokers and, since the launch of XETRA, also provides fully-electronic trading facilities, whereby orders from any point in the globe are automatically inputted into the order book on the central computer.
Desert Health Products, Inc., Announces Contract With EIC for Sales to American Indian Nations
Friday February 6, 8:00 am ET
SCOTTSDALE, Ariz., Feb. 6, 2004 (PRIMEZONE) -- Desert Health Products, Inc. (OTC BB: DHPI.OB - News) headquartered in Scottsdale, Arizona, announced today that it has entered into a ten year agreement with EIC, Inc., of Scottsdale, Arizona, to represent all of DHPI's products, including Desert Health's Foot Care System, to Mexico and all Indian Nations within the United States.
Johnny Shannon, Chairman and CEO of Desert Health Products, Inc., says, ``We are pleased to be working with EIC, and its' President, R.C. 'thingy' Eisenach, on this project with Native Americans. A very high percentage of tribal members suffer from diabetes and its complications. Desert Health's Foot Care System has been designed specifically to treat the dry skin and other conditions often associated with diabetes.''
Mr. Shannon continued, ``Initial shipments have commenced to the Osage Nation and Mr. Eisenach is in discussions with other Indian Nations at this time. Eisenach's international and domestic management, sales and marketing experience will be an asset to DHPI's continuing development of domestic and foreign markets.''
Mr. Eisenach has been representing Desert Health's product lines since April 2003. He succeeded in selling $35,000 worth of products last year. Mr. Eisenach's initial contract for 2004 with the Osage Nation will exceed $155,000, and he is in negotiations for additional contracts with the Osage Nation and other Indian Nations. He also has a pending agreement with a large marketing firm in Mexico for sales of DHPI's products. These additional agreements, according to Eisenach, will exceed $1,000,000 (one million) in 2004.
Desert Health Products, Inc. Announces Appointment to Medical Advisory Board
Thursday January 15, 8:00 am ET
SCOTTSDALE, Ariz., Jan. 15, 2004 (PRIMEZONE) -- Desert Health Products, Inc. (OTC BB: DHPI.OB - News) announced today that it has appointed Leonard Makowka, M.D., Ph. D., as head of DHPI's Medical Advisory Board. Dr. Makowka, a distinguished clinical surgeon, transplantation surgeon and medical researcher, is recognized as one of the world's leading authorities in hepatic science (study relating to the liver). Dr. Makowka has retired from surgical practice and has been using his medical expertise to pursue investment strategies and technology development in life sciences and other technological areas. Besides his clinical accomplishments he has served in numerous executive positions. From 1995 to 1997, he was the Executive Director of the Comprehensive Liver Disease and Treatment Center and Director of the Liver Transplant Program at St. Vincent's Medical Center in Los Angeles California. Prior to that he served as Chairman of the Department of Surgery and the Director of Transplantation Services at Cedars-Sinai Medical Center in Los Angeles California, from 1989 to 1995. Dr. Makowka was also appointed Professor of Surgery at the UCLA School of Medicine for that period.
Dr. Makowka with this agreement allows Royal Products, Inc., (RPI) a wholly owned subsidiary of DHPI, to use his name and endorsement on all RPI labels, brochures, sales literature, and audios and CD's.
Johnny Shannon, President and CEO, stated, ``Desert Health's decision to enter into an agreement with Dr. Makowka will strengthen management's ability to keep apprised of ground-breaking developments in the nutraceutical industry. Makowka's extensive knowledge of the medical field will play a significant role in Desert Health's growth and development.''
Dr. Makowka, 50, is actively involved as an advisor to, or member of the board of several companies. He was a Managing Director of Innovative Technology Partners LLC, and since May 1998 and until recently, has served on the Board of Directors of Hollis Eden Pharmaceuticals (NasdaqNM:HEPH - News). He has been a Corporate Member of Blue Shield of California since 1995.
In 1999, Dr. Makowka joined the Advisory Board of the California Association of Naturopathic Physicians. He is a member of the Board of Directors of KineMed Inc. and is on the Scientific Advisory Board of Unigen Pharmaceuticals. He is also an advisor to Source Precision Medicine, is Chief Scientific Advisor for Universal Detection Systems and a consultant to the University of Miami Medical School.
Makowka was a founding partner of After Midnight Entertainment Inc., a syndicated radio company that was acquired by Premiere Radio Networks and then Jacor.
Dr. Makowka received his M.D. degree from the University of Toronto Medical School in 1977, and M.S. and Ph.D. from the University of Toronto's Department of Pathology in 1979 and 1982. He has published over 400 articles and chapters in both clinical and basic scientific research and has lectured worldwide. As one of the world's leading surgeons in his field, he has performed hundreds of hepatobiliary and liver transplant procedures.
DHPI is an international distributor of nutrition and dietary supplements. DHPI has implemented a Global commercialization strategy for its diversified line of nutritional products. DHPI strives to give the customer the best quality vitamins and minerals at the most competitive prices.
Safe Harbor Statement: Except for historical information, the matters set forth herein, which are forward-looking statements, involve certain risks and uncertainties that could cause actual results to differ. Potential risks and uncertainties are not limited to: any perceived or actual benefits of trading on the Over-the-Counter Bulletin Board, the market acceptance and amount of sales derived from the Company's operations, the competitive environment within the nutrition and dietary supplement industry and the market acceptance and successful technical and economic implementation of the Company's operations.
Contact:
Desert Health Products, Inc.
Anita C. Gotcher
Director of Corporate Communications
(480) 951-1941
agotcher@deserthealth.com
Wednesday February 11, 8:00 am ET
SCOTTSDALE, Ariz., Feb. 11, 2004 (PRIMEZONE) -- Desert Health Products, Inc. (OTC BB: DHPI.OB - News) headquartered in Scottsdale, Arizona, today announced that it has met admission requirements and has been accepted for listing onto the Frankfurt Stock Exchange. Trading will commence on February 11th, 2004, under the symbol DHE and the German cusip (WKN) number A0BMFX.
``Listing on the Frankfurt exchange will increase the profile of Desert Health with investors, both institutional and retail, in Germany and across Europe,'' stated Johnny Shannon, Chairman and CEO of Desert Health Products, Inc. ``We have had high levels of interest expressed from European investors, and this opportunity to broaden our shareholder base comes at an excellent time for the company as we move into the next phase of our corporate growth initiative.''
``Desert Health has an exciting business concept, and we firmly believe that the company will quickly establish awareness throughout Europe through its market presence in Germany,'' said Jan-Eric Soetbeer, Managing Director of OTC Consulting & Financial Services in Germany, who assisted the company in the listing application process. ``There has already been a significant level of interest from investors who have identified Desert Health Products' unique business model, which carries both long-term potential for accelerated revenue growth and substantial profitability.''
The Frankfurt Stock Exchange is the world's third largest organized exchange-trading market in terms of turnover and dealings in securities. It accounts for more than 85 percent of the total securities turnover in Germany and is the largest of the eight German stock exchanges. It ranks third in the world behind the NYSE and NASDAQ markets. It offers its clients only floor trading through brokers and, since the launch of XETRA, also provides fully-electronic trading facilities, whereby orders from any point in the globe are automatically inputted into the order book on the central computer.
Desert Health Products, Inc., Announces Contract With EIC for Sales to American Indian Nations
Friday February 6, 8:00 am ET
SCOTTSDALE, Ariz., Feb. 6, 2004 (PRIMEZONE) -- Desert Health Products, Inc. (OTC BB: DHPI.OB - News) headquartered in Scottsdale, Arizona, announced today that it has entered into a ten year agreement with EIC, Inc., of Scottsdale, Arizona, to represent all of DHPI's products, including Desert Health's Foot Care System, to Mexico and all Indian Nations within the United States.
Johnny Shannon, Chairman and CEO of Desert Health Products, Inc., says, ``We are pleased to be working with EIC, and its' President, R.C. 'thingy' Eisenach, on this project with Native Americans. A very high percentage of tribal members suffer from diabetes and its complications. Desert Health's Foot Care System has been designed specifically to treat the dry skin and other conditions often associated with diabetes.''
Mr. Shannon continued, ``Initial shipments have commenced to the Osage Nation and Mr. Eisenach is in discussions with other Indian Nations at this time. Eisenach's international and domestic management, sales and marketing experience will be an asset to DHPI's continuing development of domestic and foreign markets.''
Mr. Eisenach has been representing Desert Health's product lines since April 2003. He succeeded in selling $35,000 worth of products last year. Mr. Eisenach's initial contract for 2004 with the Osage Nation will exceed $155,000, and he is in negotiations for additional contracts with the Osage Nation and other Indian Nations. He also has a pending agreement with a large marketing firm in Mexico for sales of DHPI's products. These additional agreements, according to Eisenach, will exceed $1,000,000 (one million) in 2004.
Desert Health Products, Inc. Announces Appointment to Medical Advisory Board
Thursday January 15, 8:00 am ET
SCOTTSDALE, Ariz., Jan. 15, 2004 (PRIMEZONE) -- Desert Health Products, Inc. (OTC BB: DHPI.OB - News) announced today that it has appointed Leonard Makowka, M.D., Ph. D., as head of DHPI's Medical Advisory Board. Dr. Makowka, a distinguished clinical surgeon, transplantation surgeon and medical researcher, is recognized as one of the world's leading authorities in hepatic science (study relating to the liver). Dr. Makowka has retired from surgical practice and has been using his medical expertise to pursue investment strategies and technology development in life sciences and other technological areas. Besides his clinical accomplishments he has served in numerous executive positions. From 1995 to 1997, he was the Executive Director of the Comprehensive Liver Disease and Treatment Center and Director of the Liver Transplant Program at St. Vincent's Medical Center in Los Angeles California. Prior to that he served as Chairman of the Department of Surgery and the Director of Transplantation Services at Cedars-Sinai Medical Center in Los Angeles California, from 1989 to 1995. Dr. Makowka was also appointed Professor of Surgery at the UCLA School of Medicine for that period.
Dr. Makowka with this agreement allows Royal Products, Inc., (RPI) a wholly owned subsidiary of DHPI, to use his name and endorsement on all RPI labels, brochures, sales literature, and audios and CD's.
Johnny Shannon, President and CEO, stated, ``Desert Health's decision to enter into an agreement with Dr. Makowka will strengthen management's ability to keep apprised of ground-breaking developments in the nutraceutical industry. Makowka's extensive knowledge of the medical field will play a significant role in Desert Health's growth and development.''
Dr. Makowka, 50, is actively involved as an advisor to, or member of the board of several companies. He was a Managing Director of Innovative Technology Partners LLC, and since May 1998 and until recently, has served on the Board of Directors of Hollis Eden Pharmaceuticals (NasdaqNM:HEPH - News). He has been a Corporate Member of Blue Shield of California since 1995.
In 1999, Dr. Makowka joined the Advisory Board of the California Association of Naturopathic Physicians. He is a member of the Board of Directors of KineMed Inc. and is on the Scientific Advisory Board of Unigen Pharmaceuticals. He is also an advisor to Source Precision Medicine, is Chief Scientific Advisor for Universal Detection Systems and a consultant to the University of Miami Medical School.
Makowka was a founding partner of After Midnight Entertainment Inc., a syndicated radio company that was acquired by Premiere Radio Networks and then Jacor.
Dr. Makowka received his M.D. degree from the University of Toronto Medical School in 1977, and M.S. and Ph.D. from the University of Toronto's Department of Pathology in 1979 and 1982. He has published over 400 articles and chapters in both clinical and basic scientific research and has lectured worldwide. As one of the world's leading surgeons in his field, he has performed hundreds of hepatobiliary and liver transplant procedures.
DHPI is an international distributor of nutrition and dietary supplements. DHPI has implemented a Global commercialization strategy for its diversified line of nutritional products. DHPI strives to give the customer the best quality vitamins and minerals at the most competitive prices.
Safe Harbor Statement: Except for historical information, the matters set forth herein, which are forward-looking statements, involve certain risks and uncertainties that could cause actual results to differ. Potential risks and uncertainties are not limited to: any perceived or actual benefits of trading on the Over-the-Counter Bulletin Board, the market acceptance and amount of sales derived from the Company's operations, the competitive environment within the nutrition and dietary supplement industry and the market acceptance and successful technical and economic implementation of the Company's operations.
Contact:
Desert Health Products, Inc.
Anita C. Gotcher
Director of Corporate Communications
(480) 951-1941
agotcher@deserthealth.com